Mediba Inc. is a Overseas Corporation, established on 2 Aug 2016 and registered in NO.60, SHWE DAGON PAGODA ROAD, # 401-405, PRIME HILL BUSINESS SQUARE, DAGON, YANGON, MYANMAR. The MyCO registration number is 107850155. Mediba Inc. has been operating for 10 years and its current status is Deregistered.
Profile
Company DetailsCompany record
- Legal name
- Mediba Inc.
- Local name
- MEDIBA INC. YANGON BRANCH
- Registration number
- 107850155
- Prior registration number
- 375FC/2016-2017(YGN)
- Entity type
- Overseas Corporation
- Status
- Deregistered
- Registered date
- 2 Aug 2016
- Total shares
- 0
- Business activities
- Not stated in the MyCO record
- Holding company
- JPN
- Filing dates
- Annual return due 28 Apr 2020
Contact DetailsRegistered contact information
- Registered address
- NO.60, SHWE DAGON PAGODA ROAD, # 401-405, PRIME HILL BUSINESS SQUARE, DAGON, YANGON, MYANMAR
- Postal address
- Not stated in the MyCO record
- Telephone
- Locked🔒
- Email
- Locked🔒
People
ManagementRecorded directors and officers
- EBATA TOMOHIRODirector · Japan
- OHORI MASUHIRODirector · Japan
- TANNO YUTAKADirector · Japan
- KUMIKO KOMOAuthorised Officer · Japan
ShareholderShareholding of Mediba Inc.
Ownership records and shareholder relationships require premium access.
- ✓Shareholder names and holdings
- ✓Ownership percentages and changes
Financial
Credit RatingCredit rating for Mediba Inc.
Credit assessment and supporting financial indicators require premium access.
- ✓Credit rating and payment profile
- ✓Financial strength and risk indicators
Risk
Government ConnectionGovernment connection checks for Mediba Inc.
Government ownership, control, and politically exposed person links require premium access.
- ✓Government ownership and control checks
- ✓Politically exposed person links
Litigation checks for Mediba Inc.
Court records and material dispute intelligence require premium access.
- ✓Civil and commercial court records
- ✓Case status and material outcomes
Regulatory checks for Mediba Inc.
Regulatory actions, sanctions, and compliance findings require premium access.
- ✓Regulatory actions and sanctions
- ✓Licence and compliance findings
Adverse media checks for Mediba Inc.
Source-screened media coverage and reputational risk signals require premium access.
- ✓Source-screened media coverage
- ✓Material allegations and reputational signals
